Concepedia

Thomas Vanhove

TV

14

Publications

572

Citations

13

H-Index

2010

Active since

Affiliations

KU Leuven(Current)

University Medical Center Utrecht

Karolinska University Hospital

Karolinska Institutet

Thomas Vanhove is an author at KU Leuven specializing in molecular pharmacology, urology, and renal inflammation.

ORCID

Top concepts

Publications per year

2010–2019

14

Publications

14

High Intrapatient Variability of Tacrolimus Concentrations Predicts Accelerated Progression of Chronic Histologic Lesions in Renal Recipients

Thomas Vanhove, Tom Vermeulen, Pieter Annaert et al. · American Journal of Transplantation · 2016 · 130 citations · Full text

Determinants of the Magnitude of Interaction Between Tacrolimus and Voriconazole/Posaconazole in Solid Organ Recipients

Thomas Vanhove, Hanneke Bouwsma, Luuk B. Hilbrands et al. · American Journal of Transplantation · 2017 · 86 citations · Full text

Reasons for dose reduction of mycophenolate mofetil during the first year after renal transplantation and its impact on graft outcome

Thomas Vanhove, Dirk Kuypers, Kathleen Claes et al. · Transplant International · 2013 · 64 citations

Progressive decline in tacrolimus clearance after renal transplantation is partially explained by decreasing CYP3A4 activity and increasing haematocrit

Hylke de Jonge, Thomas Vanhove, Henriëtte de Loor et al. · British Journal of Clinical Pharmacology · 2015 · 56 citations · Full text

Effect of the Direct Oral Anticoagulants Rivaroxaban and Apixaban on the Disposition of Calcineurin Inhibitors in Transplant Recipients

Thomas Vanhove, Isabel Spriet, Pieter Annaert et al. · Therapeutic Drug Monitoring · 2016 · 43 citations · Full text

Rows per page

1–5 of 14